High Glucose-induced IKK-Hsp-90 Interaction Contributes to Endothelial Dysfunction

Overview

Journal Am J Physiol Cell Physiol

Publisher American Physiological Society

Specialties Cell Biology
Physiology

Date 2008 Oct 24

PMID 18945937

Citations 22

Authors

Sumathy Mohan

Ryszard Konopinski

Bo Yan

Victoria E Centonze

Mohan Natarajan

Affiliations

Soon will be listed here.

Abstract

A decline in the bioavailability of nitric oxide (NO) that causes endothelial dysfunction is a hallmark of diabetes. The availability of NO to the vasculature is regulated by endothelial nitric oxide synthase (eNOS) activity and the involvement of heat shock protein-90 (Hsp-90) in the regulation of eNOS activity has been demonstrated. Hsp-90 has been shown to interact with upstream kinases [inhibitor kappaB kinases (IKK)alpha, beta, and gamma] in nonvascular cells. In this study, we have investigated the interaction of Hsp-90-IKKbeta in endothelial cells under conditions of high glucose (HG) as a possible mechanism that diminishes Hsp-90-eNOS interaction, which could contribute to reduced bioavailability of NO. We report for the first time that IKKbeta interacts with Hsp-90, and this interaction is augmented by HG in vascular endothelial cells. HG also augments transcriptional (3.5 +/- 0.65-fold) and translational (1.97 +/- 0.17-fold) expression as well as the catalytic activity of IKKbeta (2.45 +/- 0.4-fold). Both IKKbeta and eNOS could be coimmunoprecipitated with Hsp-90. Inhibition of Hsp-90 with geldanamycin (2 microM) or Radicicol (20 microM) mitigated (0.45 +/- 0.04-fold and 0.93 +/- 0.16-fold, respectively) HG induced-IKKbeta activity (2.5 +/- 0.42-fold). Blocking of IKKbeta expression by IKK inhibitor II (15 microM wedelolactone) or small interferring RNA (siRNA) improved Hsp-90-eNOS interaction and NO production under conditions of HG. These results illuminate a possible mechanism for the declining eNOS activity reported under conditions of HG.

Citing Articles

REDD1 Is a Promising Therapeutic Target to Combat the Development of Diabetes Complications: A Report on Research Supported by Pathway to Stop Diabetes.

Sunilkumar S, Dennis M Diabetes. 2024; 73(10):1553-1562.

PMID: 38976480 PMC: 11417436. DOI: 10.2337/dbi24-0013.

Cardioprotective Strategies After Ischemia-Reperfusion Injury.

Zhang H, Hu H, Zhai C, Jing L, Tian H Am J Cardiovasc Drugs. 2023; 24(1):5-18.

PMID: 37815758 PMC: 10806044. DOI: 10.1007/s40256-023-00614-4.

The Impacts of Animal-Based Diets in Cardiovascular Disease Development: A Cellular and Physiological Overview.

Najjar R J Cardiovasc Dev Dis. 2023; 10(7).

PMID: 37504538 PMC: 10380617. DOI: 10.3390/jcdd10070282.

NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet.

Daniel P, Dogra S, Rawat P, Choubey A, Khan A, Rajak S J Biol Chem. 2021; 296:100714.

PMID: 33930463 PMC: 8144664. DOI: 10.1016/j.jbc.2021.100714.

Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.

Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G Signal Transduct Target Ther. 2020; 5(1):293.

PMID: 33361764 PMC: 7758411. DOI: 10.1038/s41392-020-00454-7.

References

Lei H, Venkatakrishnan A, Yu S, Kazlauskas A . Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J Biol Chem. 2007; 282(13):9364-9371. DOI: 10.1074/jbc.M608985200. View

Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H . Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998; 70(13):2446-53. DOI: 10.1021/ac9801723. View

Wadham C, Parker A, Wang L, Xia P . High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes. 2007; 56(11):2715-21. DOI: 10.2337/db06-1294. View

Broemer M, Krappmann D, Scheidereit C . Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation. Oncogene. 2004; 23(31):5378-86. DOI: 10.1038/sj.onc.1207705. View

De Vriese A, Verbeuren T, Van de Voorde J, Lameire N, Vanhoutte P . Endothelial dysfunction in diabetes. Br J Pharmacol. 2000; 130(5):963-74. PMC: 1572156. DOI: 10.1038/sj.bjp.0703393. View

Balligand J . Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)?. Circ Res. 2002; 90(8):838-41. DOI: 10.1161/01.res.0000018173.10175.ff. View

Xu H, Shi Y, Wang J, Jones D, Weilrauch D, Ying R . A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function. J Biol Chem. 2007; 282(52):37567-74. DOI: 10.1074/jbc.M706464200. View

Rathel T, Leikert J J, Vollmar A, Dirsch V . Application of 4,5-diaminofluorescein to reliably measure nitric oxide released from endothelial cells in vitro. Biol Proced Online. 2003; 5:136-142. PMC: 162170. DOI: 10.1251/bpo55. View

Miao R, Fontana J, Fulton D, Lin M, Harrison K, Sessa W . Dominant-negative Hsp90 reduces VEGF-stimulated nitric oxide release and migration in endothelial cells. Arterioscler Thromb Vasc Biol. 2007; 28(1):105-11. DOI: 10.1161/ATVBAHA.107.155499. View

10.

Harris M, Ju H, Venema V, BLACKSTONE M, Venema R . Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release. Gen Pharmacol. 2001; 35(3):165-70. DOI: 10.1016/s0306-3623(01)00104-5. View

11.

Yetik-Anacak G, Catravas J . Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol. 2006; 45(5):268-76. DOI: 10.1016/j.vph.2006.08.002. View

12.

Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C . KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci. 2003; 116(Pt 18):3721-8. DOI: 10.1242/jcs.00691. View

13.

Forstermann U, Munzel T . Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006; 113(13):1708-14. DOI: 10.1161/CIRCULATIONAHA.105.602532. View

14.

Reynaert N, Ckless K, Korn S, Vos N, Guala A, Wouters E . Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A. 2004; 101(24):8945-50. PMC: 428452. DOI: 10.1073/pnas.0400588101. View

15.

Cai H, Harrison D . Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000; 87(10):840-4. DOI: 10.1161/01.res.87.10.840. View

16.

Gratton J, Fontana J, OConnor D, Garcia-Cardena G, McCabe T, Sessa W . Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem. 2000; 275(29):22268-72. DOI: 10.1074/jbc.M001644200. View

17.

MARSHALL H, Stamler J . Inhibition of NF-kappa B by S-nitrosylation. Biochemistry. 2001; 40(6):1688-93. DOI: 10.1021/bi002239y. View

18.

Sud N, Sharma S, Wiseman D, Harmon C, Kumar S, Venema R . Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol. 2007; 293(6):L1444-53. DOI: 10.1152/ajplung.00175.2007. View

19.

Pittet J, Lee H, Pespeni M, OMahony A, Roux J, Welch W . Stress-induced inhibition of the NF-kappaB signaling pathway results from the insolubilization of the IkappaB kinase complex following its dissociation from heat shock protein 90. J Immunol. 2004; 174(1):384-94. DOI: 10.4049/jimmunol.174.1.384. View

20.

Kim F, Tysseling K, Rice J, Pham M, Haji L, Gallis B . Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol. 2005; 25(5):989-94. DOI: 10.1161/01.ATV.0000160549.60980.a8. View